Alumis Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Martin Babler, with a market cap of $2.9B.
Common questions about Alumis Inc.
Alumis Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $3.0M.
Alumis Inc. has approximately 147 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.